Magnify Biosciences operates in the biotechnology sector, providing advanced imaging solutions for research scientists, medical practitioners, and biotechnology professionals. The company's core product, Magnify, leverages proprietary AI technology to deliver highly accurate predictions of therapeutic outcomes and enables nanoimaging using conventional microscopes. This allows users to achieve high-resolution images of biological specimens without the need for expensive hardware upgrades. Magnify Biosciences serves clients involved in basic research, clinical tests, and drug development, offering a cost-effective method to gain unprecedented insights into cellular structures and functions. The business model is centered around providing robust imaging solutions that facilitate significant breakthroughs in understanding diseases, such as cancer, and developing targeted drugs. Revenue is generated through the sale of their imaging platform and associated services.

Keywords: AI-powered, nanoimaging, biotechnology, high-resolution, biological research, therapeutic outcomes, cellular structures, drug development, cost-effective, imaging solutions.